Search for: "Patrick v. Patrick" Results 1 - 20 of 3,982
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Apr 2024, 10:28 am by admin
The Court of Appeals affirmed sanctions against Egilman’s co-conspirator, for what the court described as “brazen” conduct.[5]   Despite being a confessed contemnor, Egilman managed to attract a fair amount of hagiographic commentary.[6] An article in Science, described Egilman as “the scourge of companies he accuses of harming public health and corrupting science,”[7] and quoted fawning praise from his lawsuit industry employers: “[h]e’s a bloodhound… [read post]
26 Apr 2024, 6:30 am
Schwartz, Sullivan & Cromwell LLP, on Wednesday, April 24, 2024 Tags: Disclosure, Macquarie v. [read post]
26 Apr 2024, 6:30 am
Schwartz, Sullivan & Cromwell LLP, on Wednesday, April 24, 2024 Tags: Disclosure, Macquarie v. [read post]
25 Apr 2024, 12:17 pm by Eleonora Rosati
Until recently, the leading decision addressing the provision was the High Court decision in Nova Productions v Mazooma Games. [read post]
22 Apr 2024, 4:28 am by Andrew Lavoott Bluestone
Co., 5 NY3d 561, 572; Yenrab, Inc. v 794 Linden Realty, LLC, 68 AD3d 755, 758; see also Donenfeld v Brilliant Tech. [read post]
18 Apr 2024, 1:44 pm by Patricia Hughes
Patrick Webber, the founder and president of Webber Academy, was the school’s spokesperson and, it appears, the real decision-maker, although there was also a board of directors. [read post]
18 Apr 2024, 11:42 am
As, I might add, did the defendant.Here's how the traffic stop went down:"In July 2020, Officers Dorin Buchanan and Patrick Marshal pulled over Victor Ramirez after witnessing him speed in a residential neighborhood, fail to stop at a stop sign, and not use a turn signal. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]